Stockscreener 앱 받기
9.55
4.60%
-0.46
전일 마감가:
$10.01
열려 있는:
$9.88
하루 거래량:
21,295
Relative Volume:
3.19
시가총액:
$647.83M
수익:
$277.56M
순이익/손실:
$-13.33M
주가수익비율:
-50.26
EPS:
-0.19
순현금흐름:
$-6.54M
1주 성능:
-3.83%
1개월 성능:
+4.95%
6개월 성능:
+12.22%
1년 성능:
-21.27%
1일 변동 폭
$9.29
$9.99
1주일 범위
$9.29
$10.01
52주 변동 폭
$6.65
$13.20
Pharming Group N V Adr Stock (PHAR) Company Profile
PHAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
9.55 | 647.83M | 277.56M | -13.33M | -6.54M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-09 | 개시 | Jefferies | Buy |
Pharming Group N V Adr 주식(PHAR)의 최신 뉴스
Pharming Group (OTCMKTS:PHGUF) Shares Cross Above 50 Day Moving Average – Time to Sell? - Defense World
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com India
Pharming announces public cash offer to the shareholders of Abliva AB - GlobeNewswire Inc.
H.C. Wainwright reiterates Buy on Pharming stock, pediatric trial shows safety and tolerability - Investing.com India
Jefferies initiates Pharming Group shares with Buy on revenue growth - Investing.com India
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com India
Earnings call: Pharming Group NV reports growth amid CEO transition - Investing.com
Earnings call: Pharming Group NV sees robust growth in Q3, CEO to step down - Investing.com
October 2024's Promising Penny Stocks to Watch - Yahoo Finance
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com India
Pharming Group stock hits 52-week low at $6.9 amid challenges - Investing.com
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up - Nasdaq
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Zacks Investment Research
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
Pharming Group N V Adr (PHAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):